drugset / Trial / NCT04592731

Acetylated Natural Nucleotides in Treating Hand-foot Syndrome

NCT04592731 ↗

Completed 21 enrolled Nan xu
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The clinical trial is planned to investigate the efficacy and safety of acetylated natural nucleotides in treating anti-cancer medications induced hand-foot syndrome (HFS).

Timeline

Start
2020-11-03
Primary completion
2022-04-30
Completion
2022-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetylated Natural Nucleotides Unknown — —

Indications